- KDIGO Guideline for Transplant Recipients
- KDIGO Guideline for CKD-MBD
- KDIGO Guideline for Hep C in CKD
- KDIGO Guideline for Acute Kidney Injury
- KDIGO Guideline for Anemia in CKD
- KDIGO Guideline for Blood Pressure in CKD
- KDIGO Guideline for CKD Classification and Management
- KDIGO Guideline for Glomerulonephritis (GN)
- Participate in the Review Process
- Description of Guideline Development Process
Kidney Disease: Improving Global Outcomes (KDIGO)
About Us
MISSION STATEMENT
HISTORY
RATIONALE
OVERVIEW & ACTIVITIES
GOVERNANCE
MISSION STATEMENT
To improve the care and outcomes of kidney disease patients worldwide through promoting coordination, collaboration and integration of initiatives to develop and implement clinical practice guidelines.
HISTORY
Kidney Disease Improving Global Outcomes (KDIGO) was established in 2003 as an independently incorporated non-profit foundation governed by an international Board.
KDIGO is managed by the National Kidney Foundation, a U.S. foundation with 11 years of experience in developing and implementing guidelines.
Click here for a more detailed description of why and how KDIGO was created.
KDIGO Celebrates its Five-Year Anniversary (
719KB)
Rationale for a Global Initiative
- There is an increasing prevalence of kidney disease worldwide.
- The complications and problems of patients with kidney disease are universal.
- There is a need to develop a public health approach to this global epidemic of kidney disease.
- Resources may vary, but the science and evidence-based care of complications and problems encountered by those afflicted the CKD are universal and independent of geographical location or national borders.
- There is a clear need for strategic initiatives, which will improve the care of patients with kidney disease worldwide.
- It is important to increase the efficiency of utilizing available expertise and resources in improving global outcomes of kidney disease and avoid duplication of efforts.
- There is room for improving international cooperation in the development, dissemination and implementation of clinical practice guidelines to achieve these goals.
OVERVIEW & ACTIVITIES
KDIGO – Structure and Function ( 146KB)
KDIGO sponsors a variety of initiatives to achieve its goal:
- Clinical Practice Guidelines
- Controversies Conferences
- Guideline Database
- Publications
- Guideline Implementation Task Force
- Global Guideline Coordination Group
GOVERNANCE
KDIGO is led by an international Board comprised of approximately 50 members. The majority of the Board members are practicing nephrologists, but also included are patient representatives, plus delegates from other medical specialties and disciplines – nephrology nurses, dieticians and social workers. The Board elects an 11 member Executive Committee (Current Roster), which plans and oversees KDIGO’s activities and is chaired by two KDIGO Board members, who are elected to serve as co–chairs of KDIGO. The current KDIGO Co–Chairs are Kai–Uwe Eckardt, Erlangen, Germany and Bertram Kasiske, Minneapolis, USA. 
All positions are rotated and a nominating committee proposes new members of the board, the executive committee and the co–chairs each year. Former board members form a Board of Councilors, which advises and makes recommendations for KDIGO activities. For all administrative issues, KDIGO has appointed the U.S. National Kidney Foundation (NKF) as its management organization because of the considerable expertise and professionalism that the NKF has gained in guideline development during the DOQI and KDOQI process. KDIGO collaborates with professional medical organizations and because of its global mission, has a particularly strong partnership with the International Society of Nephrology. However, all members of KDIGO work groups and committees are chosen on the basis of their personal expertise and commitment and not as representatives of other organizations.
For more information on kidney disease visit the National Kidney Foundation.
*PDF files require Adobe Acrobat Reader 
